Efficacy of Liraglutide for weight loss among patients with type 2 diabetes: the SCALE diabetes randomized clinical trial
Acts on the brain's appetite-regulating centers to reduce hunger
If you ever experience serious symptoms, you must seek immediate medical attention from an A&E department or contact NHS 111
Unlike Mounjaro, which is for diabetes, Zepbound activates multiple receptors to reduce appetite effectively, delivering promising results as seen in clinical trials
All patients were informed in detail about the risks and benefits of the surgery and test meals and each provided written, informed consent to participate in the trial
Moreover, some patients may interrupt their treatment once symptoms improve, not realising the long-term necessity of ongoing supplementation to prevent recurrence of deficiency symptoms